Want more iVillage? Sign up for our
Newsletters

Vitamin C is a water-soluble vitamin that has a number of biological functions.
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.
Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.
For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.
| Used for | Amount | Why |
|---|---|---|
Anemia and Vitamin C Deficiency | 100 to 250 mg once or twice per day | Vitamin C deficiency can contribute to anemia, supplementing with this vitamin may restore levels and improve symptoms. |
| ||
| Used for | Amount | Why |
|---|---|---|
Athletic Performance and Reducing Pain and Speeding Muscle Strength Recovery after Intense Exercise | 400 mg daily for several days before and after intense exercise | Taking vitamin C for several days before and after intense exercise may reduce pain and speed muscle strength recovery. |
| ||
| Used for | Amount | Why |
|---|---|---|
Bronchitis | 200 mg daily | In a double-blind study of elderly patients hospitalized with acute bronchitis, those given vitamin C improved to a significantly greater extent than those who were given a placebo.
|
| ||
| Used for | Amount | Why |
|---|---|---|
Bruising and Vitamin C Deficiency | 400 to 800 mg daily, with flavonoids | Vitamin C supplements have been shown to reduce bruising in people with low vitamin C intake. |
| ||
| Used for | Amount | Why |
|---|---|---|
Capillary Fragility and Vitamin C Deficiency | Treat deficiency with up to 1 gram daily | In cases of deficiency, vitamin C has been shown to increase capillary strength, in seniors and people with diabetes in particular. |
| ||
| Used for | Amount | Why |
|---|---|---|
Common Cold and Sore Throat | 1 to 4 grams daily | Studies have shown that taking vitamin C may make your cold shorter and less severe. |
| ||
| Used for | Amount | Why |
|---|---|---|
Gingivitis and Vitamin C Deficiency | 300 mg daily | If you are deficient in vitamin C, supplementing with this vitamin may improve your overall gum health. |
| ||
| Used for | Amount | Why |
|---|---|---|
Glaucoma | At least 2 grams daily | Supplementing with vitamin C may help reduce intraocular pressure. |
| ||
| Used for | Amount | Why |
|---|---|---|
Heart Attack and Vitamin C Deficiency | 100 to 200 mg daily | Taking vitamin C may reduce heart attack risk and may improve the outcome for people who have already had a heart attack. |
| ||
| Used for | Amount | Why |
|---|---|---|
High Cholesterol | 1,000 mg daily | Vitamin C appears to protect LDL cholesterol from damage, and in some trials, cholesterol levels have fallen when people supplement with vitamin C. |
| ||
| Used for | Amount | Why |
|---|---|---|
Infection | 1 to 4 grams daily | Vitamin C has antiviral activity, and may help prevent viral infections or, in the case of the common cold, reduce the severity and duration of an infection. |
| ||
| Used for | Amount | Why |
|---|---|---|
Male Infertility and Sperm Agglutination | 1,000 mg daily | Vitamin C protects sperm from oxidative damage and keeps sperm from sticking together. |
| ||
| Used for | Amount | Why |
|---|---|---|
Stress | 1 to 3 grams daily | Studies have shown that supplementing with vitamin C helps to normalize stress-hormone levels. |
| ||
| Used for | Amount | Why |
|---|---|---|
Sunburn (Vitamin E) | 2,000 to 3,000 mg vitamin C and 1,000 to 2,000 IU vitamin E | Antioxidants may protect the skin from sunburn due to free radical–producing ultraviolet rays. Combinations of vitamin E and C offer protection against ultraviolet rays. |
| ||
| Used for | Amount | Why |
|---|---|---|
Wound Healing | 1 to 3 grams daily | Taking vitamin C may promote connective tissue repair. |
| ||
| Used for | Amount | Why |
|---|---|---|
Asthma | 1,000 to 1,500 mg daily | Supplementing with vitamin C reduces the tendency of the bronchial passages to go into spasm, an action that has been confirmed in double-blind research. |
| ||
| Used for | Amount | Why |
|---|---|---|
Atherosclerosis | 250 mg twice per day | Supplementing with vitamin C may help reverse the progression of atherosclerosis and protect against heart disease. |
| ||
| Used for | Amount | Why |
|---|---|---|
Athletic Performance and Vitamin C Deficiency | If deficient: 100 to 200 mg daily | Antioxidants, including vitamin C, neutralize exercise-related free radicals before they can damage the body, so antioxidants may aid in exercise recovery. Especially in cases of vitamin C deficiency, supplementing with the vitamin may improve exercise performance. |
| ||
| Used for | Amount | Why |
|---|---|---|
Autism | 1 gram per 20 lbs (9 kg) body weight per day | In one trial, autistic children given vitamin C had less severe symptoms than those taking placebo, possibly because vitamin C affects a hormone pathway typically disturbed in children with autism. |
| ||
| Used for | Amount | Why |
|---|---|---|
Cataracts | 500 to 1,000 mg daily | Supplementing with vitamin C, an important nutrient for healthy vision, has been linked with lower risk of developing cataracts. |
| ||
| Used for | Amount | Why |
|---|---|---|
Cold Sores (Flavonoids) | 200 mg with 200 mg flavonoids, three to five times daily | Vitamin C plus flavonoids may help speed cold sore healing.
|
| ||
| Used for | Amount | Why |
|---|---|---|
Dysmenorrhea (Rutin, Vitamin B3) | 200 mg niacin daily, 300 mg vitamin C daily, and 60 mg rutin daily througout menstrual cycle; for cramps: 100 mg niacin every two to three hours | Supplementing with a combination of vitamin B3, vitamin C, and the flavonoid rutin resulted in a 90% effectiveness for relieving menstrual cramps in one study. |
Endometriosis (Vitamin E) | 1,000 mg vitamin C and 1,200 IU vitamin E daily | A combination of vitamin C and vitamin E can help lessen the pain of endometriosis. |
| ||
| Used for | Amount | Why |
|---|---|---|
Female Infertility and Luteal Phase Defect | 750 mg daily | Vitamin C has been shown to improve fertility in woman with a uterine condition known as luteal phase defect. |
| ||
| Used for | Amount | Why |
|---|---|---|
Gastritis | 5 grams daily | Vitamin C may reduce free radical damage in the stomach lining in the case of gastritis caused by the bacteriaH. pylori. |
| ||
| Used for | Amount | Why |
|---|---|---|
Gingivitis (Flavonoids) | 300 mg of vitamin C, plus 300 mg of flavonoids daily | In one study, supplementing with vitamin C plus flavonoids improved gum health in a group of people with gingivitis. |
| ||
| Used for | Amount | Why |
|---|---|---|
Gout | 0.5 to 8 grams daily | Supplementing with vitamin C may reduce the risk of gout attacks, as it appears to help reduce uric acid levels. |
| ||
| Used for | Amount | Why |
|---|---|---|
Immune Function | Consult a qualified healthcare practitioner | Vitamin C stimulates the immune system. While taking it has only a small effect in preventing colds, it does significantly reduce the duration of a cold when taken at the onset. |
| ||
| Used for | Amount | Why |
|---|---|---|
Influenza | 100 mg daily | Supplementing with vitamin C may reduce your flu risk. |
| ||
| Used for | Amount | Why |
|---|---|---|
Pancreatic Insufficiency | 540 mg daily | Taking antioxidant supplements, such as vitamin C, may lessen pain and prevent pancreatitis recurrences. |
Parkinson’s Disease (Vitamin E) | 3,000 mg of vitamin C and 3,200 IU of vitamin E | Supplementing with vitamins C and E may help people with early Parkinson’s disease delay the need for medication. |
| ||
| Used for | Amount | Why |
|---|---|---|
Pre- and Post-Surgery Health and Vitamin C Deficiency | 100 to 250 mg once or twice per day | Vitamin C supports immune function and is a critical nutrient for wound healing. Supplementing with it may decrease the risk of excessive bleeding in the surgical setting. |
| ||
| Used for | Amount | Why |
|---|---|---|
Preeclampsia and High-Risk Women (Vitamin E) | 1,000 mg daily vitamin C with 400 IU vitamin E | Women with preeclampsia have been found to have low antioxidant levels. In one trial, supplementing with vitamins C and E reduced preeclampsia incidence by 76% in high-risk women. |
Pregnancy and Postpartum Support and Women on Low Vitamin C Diets | 100 mg daily | Supplementing with vitamin C during pregnancy may reduce the risk of premature rupture of membranes (PROM). |
| ||
| Used for | Amount | Why |
|---|---|---|
Schizophrenia | Consult a qualified healthcare practitioner | People with schizophrenia may require more vitamin C than the general population. In one trial, vitamin C reduced hallucinations, suspiciousness, and disorganized thoughts. |
| ||
| Used for | Amount | Why |
|---|---|---|
Skin Ulcers | 1,000 mg daily | Supplementing with vitamin C may help prevent skin ulcers and speed healing. |
| ||
| Used for | Amount | Why |
|---|---|---|
Sprains and Strains | 250 to 500 mg with meals and at bedtime | Vitamin C is needed to make collagen, the “glue” that strengthens connective tissue. Vitamin C supplementation can speed healing of various types of trauma. |
| ||
| Used for | Amount | Why |
|---|---|---|
Sunburn (Vitamin E) | Apply a formula containing 2% vitamin E and 5% vitamin C before sun exposure | Studies have found sunscreen-like effects from topical application of the vitamin C and vitamin E combination. |
| ||
| Used for | Amount | Why |
|---|---|---|
Sunburn (Melatonin, Vitamin E) | Apply a formula containing 2% vitamin E, 5% vitamin C, and 1% to 2.5% melatonin before sun exposure | A topically applied combination of melatonin, vitamin C, and vitamin E may boost the protection from traditional sunscreens. |
| ||
| Used for | Amount | Why |
|---|---|---|
Type 1 Diabetes | 500 mg twice per day | Supplementing with vitamin C may benefit people with type 1 diabetes in several ways, including by reducing sorbitol levels, urinary protein loss, glycosylation, and eye damage. |
| ||
| Used for | Amount | Why |
|---|---|---|
Type 2 Diabetes | 500 mg twice per day | Supplementing with vitamin C may benefit people with type 2 diabetes in several ways, including by reducing sorbitol levels, urinary protein loss, and glycosylation. |
| ||
| Used for | Amount | Why |
|---|---|---|
Urinary Tract Infection | Refer to label instructions | Supplementing with vitamin C may treat acute UTIs and help people who are prone to recurrent UTIs. |
| ||
| Used for | Amount | Why |
|---|---|---|
Age-Related Cognitive Decline | Refer to label instructions | Use of vitamin C, alone or with vitamin E, has been associated with better cognitive function and a reduced risk of certain forms of dementia (not including Alzheimer’s disease). |
| ||
| Used for | Amount | Why |
|---|---|---|
Alcohol Withdrawal | Refer to label instructions | Vitamin C appears to help the body rid itself of alcohol. Alcohol-related anxiety may also be improved by a combination of vitamin C, vitamin B6, niacin, and vitamin E, though the high amounts B vitamins studied need a doctor’s supervision.
|
| ||
| Used for | Amount | Why |
|---|---|---|
Amenorrhea (Clomiphene) | Refer to label instructions | Vitamin C combined with the drug clomiphene, which affects female hormone levels, is more effective at stimulating ovulation in women with amenorrhea than either substance alone. |
| ||
| Used for | Amount | Why |
|---|---|---|
Asthma (Vitamin E, Selenium) | Refer to label instructions | There is some evidence that a combination of antioxidants vitamin E, vitamin C, and selenium may help prevent asthma throught to be caused by air pollution.
|
| ||
| Used for | Amount | Why |
|---|---|---|
Bipolar Disorder | Refer to label instructions | Vitamin C helps the body reduce its load of vanadium, a mineral that adversely influences bipolar disorder. It has improved symptoms of depression and mania in some studies. |
| ||
| Used for | Amount | Why |
|---|---|---|
Childhood Diseases | Refer to label instructions | Vitamin C enhances the immune system and may protect against viral infections, including measles and chicken pox. |
| ||
| Used for | Amount | Why |
|---|---|---|
Chronic Obstructive Pulmonary Disease | Refer to label instructions | In one study, people who got more vitamin C from their diet were less likely to be diagnosed with bronchitis, however, vitamin C has not been studied in relation to COPD. |
| ||
| Used for | Amount | Why |
|---|---|---|
Colon Cancer | Refer to label instructions | Vitamin C has been shown to improve precancerous conditions in at-risk people.
|
| ||
| Used for | Amount | Why |
|---|---|---|
Ear Infections | Refer to label instructions | Supplementing with vitamin C stimulates the immune system and may help prevent ear infections. |
| ||
| Used for | Amount | Why |
|---|---|---|
Eczema | Refer to label instructions | Vitamin C might be beneficial in treating eczema by affecting the immune system. |
| ||
| Used for | Amount | Why |
|---|---|---|
Gallstones | Refer to label instructions | Vitamin C is needed for the body to convert cholesterol to bile acids and may help reduce symptoms of gallstones. |
| ||
| Used for | Amount | Why |
|---|---|---|
Halitosis, Gingivitis, and Vitamin C Deficiency | Refer to label instructions | Vitamin C is often recommended by doctors to help prevent and treat periodontitis. |
| ||
| Used for | Amount | Why |
|---|---|---|
Hay Fever | Refer to label instructions | Vitamin C has antihistamine activity, and supplementing with it has been reported to help people with hay fever. |
| ||
| Used for | Amount | Why |
|---|---|---|
Heart Attack | Refer to label instructions | Vitamin C has been reported to protect blood vessels from problems associated with heart attack risk in a variety of ways. |
| ||
| Used for | Amount | Why |
|---|---|---|
Hepatitis | Refer to label instructions | Vitamin C has been shown to be effective at preventing hepatitis infection in people receiving blood transfusions and at treating viral hepatitis. |
| ||
| Used for | Amount | Why |
|---|---|---|
HIV and AIDS Support | Refer to label instructions | Vitamin C has been shown to inhibit HIV replication in test tubes. Supplementing with it may improve resistance to infection, reduce risk of progression to AIDS, and improve well-being. |
| ||
| Used for | Amount | Why |
|---|---|---|
Hives | Refer to label instructions | High amounts of vitamin C might help people with hives by lowering histamine levels. |
| ||
| Used for | Amount | Why |
|---|---|---|
Hypertension | Refer to label instructions | Some doctors recommend that people with hypertenstion supplement with vitamin C, which has been found to have a blood pressure–lowering effect. |
| ||
| Used for | Amount | Why |
|---|---|---|
Hypoglycemia | Refer to label instructions | Vitamin C helps control blood sugar levels in diabetics, and since there are similarities in the way the body regulates high and low blood sugar levels, it might be helpful for hypoglycemia as well. |
| ||
| Used for | Amount | Why |
|---|---|---|
Leukoplakia | Refer to label instructions | Studies have shown vitamin C, in combination with beta-carotene and vitamin E, to be an effective treatment for leukoplakia. |
| ||
| Used for | Amount | Why |
|---|---|---|
Low Back Pain | Refer to label instructions | A preliminary report suggested that vitamin C helped many people avoid surgery for their disc-related low back pain. |
| ||
| Used for | Amount | Why |
|---|---|---|
Macular Degeneration | Refer to label instructions | Sunlight triggers oxidative damage in the eye, which in turn can cause macular degeneration. Vitamin C protects against oxidative damage and may reduce macular degeneration risk. |
| ||
| Used for | Amount | Why |
|---|---|---|
Menopause | Refer to label instructions | A combination of vitamin C and the flavonoid hesperidin were reported to relieve hot flashes in menopausal women. |
| ||
| Used for | Amount | Why |
|---|---|---|
Menorrhagia | Refer to label instructions | Vitamin C protects capillaries (small blood vessels) from damage. In so doing, it might protect against the blood loss of menorrhagia. |
| ||
| Used for | Amount | Why |
|---|---|---|
Morning Sickness | Refer to label instructions | Vitamin K and vitamin C, taken together, may provide relief of morning sickness symptoms for some women. |
| ||
| Used for | Amount | Why |
|---|---|---|
Peptic Ulcer | Refer to label instructions | Vitamin C may be useful in treating peptic ulcers because of its ability to help eradicate H. pylori |
| ||
| Used for | Amount | Why |
|---|---|---|
Prostatitis | Refer to label instructions | Vitamin C inhibits the growth of E.coli |
| ||
| Used for | Amount | Why |
|---|---|---|
Sickle Cell Anemia | Refer to label instructions | Sickle cell anemia patients tend to have low levels of antioxidants, which protect cells from oxygen-related damage. Supplementing with vitamin C may help correct a deficiency. |
| ||
| Used for | Amount | Why |
|---|---|---|
Sinusitis | 2,000 mg per day of hydroxyethylrutosides | In one study, vitamin C supplementation reduced levels of histamine, which contributes to nasal and sinus congestion, in people with either high histamine levels or low vitamin C levels. |
| ||
| Used for | Amount | Why |
|---|---|---|
Tardive Dyskinesia | Refer to label instructions | In some studies, taking vitamin C along with other nutrients appeared to prevent the development of tardive dyskinesia |
| ||
| Used for | Amount | Why |
|---|---|---|
Type 1 Diabetes (Selenium, Vitamin A, Vitamin E) | Refer to label instructions | A combination of the antioxidants selenium, vitamin A, vitamin C, and vitamin E has been shown to improve diabetic retinopathy. |
| ||
| Used for | Amount | Why |
|---|---|---|
Type 1 Diabetes and Diabetic Retinopathy (Selenium, Vitamin A, Vitamin E) | Refer to label instructions | Antioxidant nutrients including selenium, vitamin A, vitamin C, and vitamin E may combat free radicals associated with diabetic retinopathy. |
| ||
| Used for | Amount | Why |
|---|---|---|
Type 2 Diabetes and Diabetic Neuropathy (Selenium, Vitamin A, Vitamin E) | Refer to label instructions | A combination of the antioxidants selenium, vitamin A, vitamin C, and vitamin E has been shown to improve diabetic retinopathy. |
| ||
| Used for | Amount | Why |
|---|---|---|
Vitiligo | Refer to label instructions | Vitamin C has been shown to be effective at skin repigmentation in people with vitiligo. |
| ||
1. Little DR. Ambulatory management of common forms of anemia. Am Fam Physician 1999;59:1598–604 [review].
2. Hodges RE, Sauberlich HE, Canham JE, et al. Hematopoietic studies in vitamin A deficiency. Am J Clin Nutr 1978;31:876–85 [review].
3. Bloem MW. Interdependence of vitamin A and iron: an important association for programmes of anaemia control. Proc Nutr Soc 1995;54:501–8 [review].
4. Lane M, Alfrey CP. The anemia of human riboflavin deficiency. Blood 1965;25:432–42.
5. Orehek AJ, Kollas CD. Refractory postpartum anemia due to vitamin B6 deficiency. Ann Intern Med 1997;126(10):834–5 [letter].
6. Iwama H, Iwase O, Hayashi S, et al. Macrocytic anemia with anisocytosis due to alcohol abuse and vitamin B6 deficiency. Rinsho Ketsueki 1998;39:1127–30 [in Japanese].
7. Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol 1999;41:895–906 [review].
8. Summerfield AL, Steinberg FU, Gonzalez JG. Morphologic findings in bone marrow precursor cells in zinc-induced copper deficiency anemia. Am J Clin Pathol 1992;97:665–8.
9. Freycon F, Pouyau G. Rare nutritional deficiency anemia: deficiency of copper and vitamin E. Sem Hop 1983;59:488–93 [review] [in French].
10. Borgna-Pignatti C, Marradi P, Pinelli L, et al. Thiamine-responsive anemia in DIDMOAD syndrome. J Pediatr 1989;114:405–10.
11. Neufeld EJ, Mandel H, Raz T, et al. Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genet 1997;61:1335–41.
12. Kanter M. Free radicals, exercise and antioxidant supplementation. Proc Nutr Soc 1998;57:9–13 [review].
13. Dekkers JC, Van Doornen LJ, Kemper HC. The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med 1996;21(3):213–38 [review].
14. Jakeman P, Maxwell S. Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise. Eur J Appl Physiol 1993;67:426–30.
15. Kaminski M, Boal R. An effect of ascorbic acid on delayed-onset muscle soreness. Pain 1992;50:317–21.
16. Thompson D, Williams C, McGregor SJ, et al. Prolonged vitamin C supplementation and recovery from demanding exercise. Int J Sport Nutr Exerc Metab 2001;11:466–81.
17. Thompson D, Williams C, Garcia-Roves P, et al. Post-exercise vitamin C supplementation and recovery from demanding exercise. Eur J Appl Physiol 2003;89:393–400.
18. Itoh H, Ohkuwa T, Yamazaki Y, et al. Vitamin E supplementation attenuates leakage of enzymes following 6 successive days of running training. Int J Sports Med 2000;21:369–74.
19. McBride JM, Kraemer WJ, Triplett-McBride T, Sebastianelli W. Effect of resistance exercise on free radical production. Med Sci Sports Exerc 1998;30:67–72.
20. Evans WJ. Vitamin E, vitamin C, and exercise. Am J Clin Nutr 2000;72:647S–52S [review].
21. Dawson B, Henry GJ, Goodman C, et al. Effect of Vitamin C and E supplementation on biochemical and ultrastructural indices of muscle damage after a 21 km run. Int J Sports Med 2002;23:10–15.
22. Beaton LJ, Allan DA, Tarnopolsky MA, et al. Contraction-induced muscle damage is unaffected by vitamin E supplementation. Med Sci Sports Exerc 2002;34:798–805.
23. Petersen EW, Ostrowski K, Ibfelt T, et al. Effect of vitamin supplementation on cytokine response and on muscle damage after strenuous exercise. Am J Physiol Cell Physiol 2001;280:C1570–5.
24. Kanter MM, Nolte LA, Holloszy JO. Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J Appl Physiol 1993;74:965–9.
25. Kaikkonen J, Kosonen L, Nyyssonen K, et al. Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate supplementaion on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners. Free Radic Res 1998;29:85–92.
26. Singh A, Failla ML, Deuster PA. Exercise-induced changes in immune function: effects of zinc supplementation. J Appl Physiol 1994;76:2298–303.
27. Johnston CS, Swan PD, Corte C. Substrate utilization and work efficiency during submaximal exercise in vitamin C depleted-repleted adults. Int J Vitam Nutr Res 1999;69:41–4.
28. Gerster H. The role of vitamin C in athletic performance. J Am Coll Nutr 1989;8:636–43 [review].
29. Tiidus PM, Houston ME. Vitamin E status and response to exercise training. Sports Med 1995;20:12–23 [review].
30. Akova B, Surmen-Gur E, Gur H, et al. Exercise-induced oxidative stress and muscle performance in healthy women: role of vitamin E supplementation and endogenous oestradiol. Eur J Appl Physiol 2001;84:141–7.
31. Simon-Schnass I, Pabst H. Influence of vitamin E on physical performance. Int J Vitam Nutr Res 1988;58:49–54.
32. Shepard RJ. Vitamin E and athletic performance. J Sports Med 1983;23:461–70 [review].
33. Hunt C, Chakravorty NK, Annan G, et al. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res 1994;64:212–9.
34. Hemilä H. Does vitamin C alleviate the symptoms of the common cold?—A review of current evidence. Scand J Infect Dis 1994;26:1–6.
35. Menzel DB. Antioxidant vitamins and prevention of lung disease.Ann N Y Acad Sci 1992;669:141–55.
36. Schorah CJ, Tormey WP, Brooks GH, et al. The effect of vitamin C supplements on body weight, serum proteins, and general health of an elderly population. Am J Clin Nutr 1981;34:871–6.
37. Shamrai EF. Vitamin P. Its chemical nature and mechanism of physiologic action. Uspekhi Sovremennoi Biologii 1968;65:186–201.
38. Horoschak A. Nocturnal leg cramps, easy bruisability and epistaxis in menopausal patients: treated with hesperidin and ascorbic acid. Delaware State Med J 1959;Jan:19–22.
39. Reinhold U, Seiter S, Ugurel S, Tilgen W. Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients. J Am Acad Dermatol 1999;41:207–8.
40. Bradley DW, Maynard JE, Webster H. Plasma and whole blood concentrations of ascorbic acid in patients undergoing long-term hemodialysis. Am J Clin Pathol 1973;60:145–7.
41. Sullivan JF, Eisenstein AB. Ascorbic acid depletion during hemodialysis. JAMA 1972;220:1697–9.
42. Tomson CR, Channon SM, Parkinson IS. Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility. Clin Chim Acta 1989;180:255–64.
43. Cox BD, Butterfield WJ. Vitamin C supplements and diabetic cutaneous capillary fragility. Br Med J 1975;3:205.
44. Will JC, Byers T. Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 1996;54:193–202 [review].
45. Schorah CJ, Tormey WP, Brooks GH, et al. The effect of vitamin C supplements on body weight, serum proteins, and general health of an elderly population. Am J Clin Nutr 1981;34:871–6.
46. Hemilä H. Does vitamin C alleviate the symptoms of the common cold?—a review of current evidence. Scand J Infect Dis 1994;26:1–6.
47. Hemilä H. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit. Med Hypotheses 1999;52:171–8.
48. Vaananen MK, Markkanen HA, Tuovinen VJ, et al. Periodontal health related to plasma ascorbic acid. Proc Finn Dent Soc 1993;89:51–9.
49. Aurer-Kozelj J, Kralj-Klobucar N, Buzina R, Bacic M. The effect of ascorbic acid supplementation on periodontal tissue ultrastructure in subjects with progressive periodontitis. Int J Vitam Nutr Res 1982;52:333–41.
50. Ringsdorf WM Jr, Cheraskin E. Ascorbic acid and glaucoma: a review. J Holistic Med 1981;3:167–72.
51. Boyd HH. Eye pressure lowering effect of vitamin C. J Orthomolec Med 1995;10:165–8.
52. Chambers JC, McGergor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156–60.
53. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996;119:139–50.
54. Rath M, Pauling L. Solution to the puzzle of human cardiovascular disease: Its primary cause is ascorbate deficiency leading to the deposition of lipoprotein (a) and fibrinogen/fibrin in the vascular wall. J Orthomol Med 1992;6:125–34.
55. Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation 1992;85:865 [abstract].
56. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:261–6.
57. Nyyssönen K, Parvianinen MT, Salonen R, et al. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997;314:634–8.
58. Simon JA, Hudes ES, Browner WS. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiology 1998;9:316–21.
59. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450–6.
60. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113–8S.
61. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992;11:107–27.
62. Gatto LM, Hallen GK, Brown AJ, Samman S. Ascorbic acid induces a favorable lipoprotein profile in women. J Am Coll Nutr 1996;15;154–8.
63. Balz F. Antioxidant Vitamins and Heart Disease. Presented at the 60th Annual Biology Colloquium, Oregon State University, February 25, 1999.
64. Geber WF, Lefkowitz SS, Hung CY. Effect of ascorbic acid, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Pharmacology 1975;13:228–33.
65. Hemila H. Vitamin C and the common cold. Br J Nutr 1992;67:3–16.
66. Fraga CG, Motchnik PA, Shigenaga MK, et al. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci 1991;88:11003–6.
67. Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril 1992;58:1034–9.
68. Dawson EB, Harris WA, McGanity WJ. Effect of ascorbic acid on sperm fertility. Fed Proc 1983;42:531 [abstr 31403].
69. Dawson EB, Harris WA, Powell LC. Relationship between ascorbic acid and male fertility. In: Aspects of Some Vitamins, Minerals and Enzymes in Health and Disease, ed. GH Bourne. World Rev Nutr Diet 1990;62:1–26 [review].
70. Dawson EB, Harris WA, Rankin WE, et al. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci 1987;498:312–23.
71. Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 1999;14:1028–33.
72. Pardue SL, Thaxton JP, Brake J. Role of ascorbic acid in chicks exposed to high environmental temperature. J Appl Physiol 1985;58:1511–6.
73. Doulas NL, Constantopoulos A, Litsios B. Effect of ascorbic acid on guinea pig adrenal adenylate cyclase activity and plasma cortisol. J Nutr1987;117:1108–14.
74. Zhou X, Xie M, Niu C, Sun R. The effects of dietary vitamin C on growth, liver vitamin C and serum cortisol in stressed and unstressed juvenile soft-shelled turtles (Pelodiscus sinensis). Comp Biochem Physiol A Mol Integr Physiol 2003;135:263–70.
75. Satterlee DG, Aguilera-Quintana I, Munn BJ, Krautmann BA. Vitamin C amelioration of the adrenal stress response in broiler chickens being prepared for slaughter. Comp Biochem Physiol A 1989;94:569–74.
76. Peters EM, Anderson R, Nieman DC, et al. Vitamin C supplementation attenuates the increases in circulating cortisol, adrenaline and anti-inflammatory polypeptides following ultramarathon running. Int J Sports Med 2001;22:537–43.
77. Peters EM, Anderson R, Theron AJ. Attenuation of increase in circulating cortisol and enhancement of the acute phase protein response in vitamin C-supplemented ultramarathoners. Int J Sports Med 2001;22:120–6.
78. Gromova EG, Sviridova SP, Kushlinskii NE, et al. Regulation of the indices of neuroendocrine status in surgical patients with lung cancer using optimal doses of ascorbic acid. Anesteziol Reanimatol1990;5:71–4 [in Russian].
79. Brody S, Preut R, Schommer K, Schurmeyer TH. A randomized controlled trial of high dose ascorbic acid for reduction of blood pressure, cortisol, and subjective responses to psychological stress. Psychopharmacology (Berl) 2002;159:319–24.
80. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic Biol Med 1998;25:848–73.
81. Werninghaus K, Meydani M, Bhawan J, et al. Evaluation of the photoprotective effect of oral vitamin E supplementation. Arch Dermatol 1994;130:1257–61.
82. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med 1998;25:1006–12.
83. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol 1998;38:45–8.
84. McArdle F, Rhodes LE, Parslew RA, et al. Effects of oral vitamin E and beta-carotene supplementation on ultraviolet radiation-induced oxidative stress in human skin. Am J Clin Nutr 2004;80:1270–5.
85. Garmyn M, Ribaya-Mercado JD, Russel RM, et al. Effect of beta-carotene supplementation on the human sunburn reaction. Exp Dermatol 1995;4:104–11.
86. Wolf C, Steiner A, Honigsmann H, et al. Do oral carotenoids protect human skin against UV erythema, psoralen phototoxicity, and UV-induced DNA damage? J Invest Dermatol 1988;90:55–57.
87. Mathews-Roth MM, Pathak MA, Parrish J, et al. A clinical trial of the effects of oral beta-carotene on the responses of human skin to solar radiation. J Invest Dermatol 1972;59:349–53.
88. Gollnick HP, Hopfenmuller W, Hemmes C, et al. Systemic B-carotene plus topical sunscreen are an optimal protection against harmful effects of natural UV-sunlight. Eur J Dermatol 1996;6:200–5.
89. Lee J, Jiang S, Levine N, Watson RR. Carotenoid supplementation reduces erythema in human skin after simulated solar radiation exposure. Proc Soc Exp Biol Med 2000;223:170–4.
90. Heinrich U, Gartner C, Wiebusch M, et al. Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. J Nutr 2003;133:98–101.
91. Aust O, Stahl W, Sies H, et al. Supplementation with tomato-based products increases lycopene, phytofluene, and phytoene levels in human serum and protects against UV-light-induced erythema. Int J Vitam Nutr Res 2005;75:54–60.
92. Cesarini JP, Michel L, Maurette JM, et al. Immediate effects of UV radiation on the skin: modification by an antioxidant complex containing carotenoids. Photodermatol Photoimmunol Photomed 2003;19:182–9.
93. Greul AK, Grundmann JU, Heinrich F, et al. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol 2002;15:307–15.
94. La Ruche G, Cesarini JP. Protective effect of oral selenium plus copper associated with vitamin complex on sunburn cell formation in human skin. Photodermatol Photoimmunol Photomed 1991;8:232–5.
95. Sies H, Stahl W. Nutritional protection against skin damage from sunlight. Annu Rev Nutr 2004;24:173–200 [review].
96. Sies H, Stahl W. Carotenoids and UV protection. Photochem Photobiol Sci 2004;3:749-52 [review].
97. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 1986;314:892–902 [review].
98. Mazzotta MY. Nutrition and wound healing. J Am Podiatr Med Assoc 1994;84:456–62 [review].
99. Mazzotta MY. Nutrition and wound healing. J Am Podiatr Med Assoc 1994;84:456–62 [review].
100. Ringsdorf WM Jr, Cheraskin E. Vitamin C and human wound healing. Oral Surg Oral Med Oral Pathol 1982;53:231–6 [review].
101. Vaxman F, Olender S, Lambert A, et al. Can the wound healing process be improved by vitamin supplementation? Experimental study on humans. Eur Surg Res 1996;28:306–14.
102. Vaxman F, Olender S, Lambert A, et al. Effect of pantothenic acid and ascorbic acid supplementation on human skin wound healing process. A double-blind, prospective and randomized trial. Eur Surg Res 1995;27:158–66.
103. Zuskin E, Valic F, Bouhuys A. Byssinosis and airway responses due to exposure to textile dust. Lung 1976;154:17–24.
104. Bucca C, Rolla G, Oliva A, Farina J-C. Effect of vitamin C on histamine bronchial responsiveness of patients with allergic rhinitis. Ann Allergy 1990;65:311–4.
105. Schachter EN, Schlesinger A. The attenuation of exercise-induced bronchospasm by ascorbic acid. Ann Allergy 1982;49:146–51.
106. Tecklenburg SL, Mickleborough TD, Fly AD, et al. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med 2007;Apr 4:Epub ahead of print.
107. Mohsenin V, Dubois AB, Douglas JS. Effect of ascorbic acid on response to methacholine challenge in asthmatic subjects. Am Rev Respir Dis 1983;127:143–7.
108. Zuskin E, Lewis AJ, Bouhuys A. Inhibition of histamine-induced airway constriction by ascorbic acid. J Allergy Clin Immunol 1973;51:218–26.
109. Ting S, Mansfield LE, Yarbrough J. Effects of ascorbic acid on pulmonary functions in mild asthma. J Asthma 1983;20:39–42.
110. Malo JL, Cartier A, Pineau L, et al. Lack of acute effects of ascorbic acid on spirometry and airway responsiveness to histamine in subjects with asthma. J Allergy Clin Immunol 1986;78:1153–8.
111. Kordansky DW, Rosenthal RR, Norman PS. The effect of vitamin C on antigen-induced bronchospasm. J Allergy Clin Immunol 1979;63:61–4.
112. Anah CO, Jarike LN, Baig HA. High dose ascorbic acid in Nigerian asthmatics. Trop Geogr Med 1980;32:132–7.
113. Ruskin SL. Sodium ascorbate in the treatment of allergic disturbances. The role of adrenal cortical hormone-sodium-vitamin C. Am J Dig Dis 1947;14:302–6.
114. Chambers JC, McGregor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156–60.
115. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S–8S.
116. Balz F. Antioxidant Vitamins and Heart Disease. Presented at the 60th Annual Biology Colloquium, Oregon State University, February 25, 1999.
117. Salonen JT, Nyyssönen K, Salonen R, et al. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamin E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000;248:177–86.
118. Kanter M. Free radicals, exercise and antioxidant supplementation. Proc Nutr Soc 1998;57:9–13 [review].
119. Dekkers JC, Van Doornen LJ, Kemper HC. The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med 1996;21(3):213–38 [review].
120. Jakeman P, Maxwell S. Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise. Eur J Appl Physiol 1993;67:426–30.
121. Kaminski M, Boal R. An effect of ascorbic acid on delayed-onset muscle soreness. Pain 1992;50:317–21.
122. Thompson D, Williams C, McGregor SJ, et al. Prolonged vitamin C supplementation and recovery from demanding exercise. Int J Sport Nutr Exerc Metab 2001;11:466–81.
123. Thompson D, Williams C, Garcia-Roves P, et al. Post-exercise vitamin C supplementation and recovery from demanding exercise. Eur J Appl Physiol 2003;89:393–400.
124. Itoh H, Ohkuwa T, Yamazaki Y, et al. Vitamin E supplementation attenuates leakage of enzymes following 6 successive days of running training. Int J Sports Med 2000;21:369–74.
125. McBride JM, Kraemer WJ, Triplett-McBride T, Sebastianelli W. Effect of resistance exercise on free radical production. Med Sci Sports Exerc 1998;30:67–72.
126. Evans WJ. Vitamin E, vitamin C, and exercise. Am J Clin Nutr 2000;72:647S–52S [review].
127. Dawson B, Henry GJ, Goodman C, et al. Effect of Vitamin C and E supplementation on biochemical and ultrastructural indices of muscle damage after a 21 km run. Int J Sports Med 2002;23:10–15.
128. Beaton LJ, Allan DA, Tarnopolsky MA, et al. Contraction-induced muscle damage is unaffected by vitamin E supplementation. Med Sci Sports Exerc 2002;34:798–805.
129. Petersen EW, Ostrowski K, Ibfelt T, et al. Effect of vitamin supplementation on cytokine response and on muscle damage after strenuous exercise. Am J Physiol Cell Physiol 2001;280:C1570–5.
130. Kanter MM, Nolte LA, Holloszy JO. Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J Appl Physiol 1993;74:965–9.
131. Kaikkonen J, Kosonen L, Nyyssonen K, et al. Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate supplementaion on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners. Free Radic Res 1998;29:85–92.
132. Singh A, Failla ML, Deuster PA. Exercise-induced changes in immune function: effects of zinc supplementation. J Appl Physiol 1994;76:2298–303.
133. Johnston CS, Swan PD, Corte C. Substrate utilization and work efficiency during submaximal exercise in vitamin C depleted-repleted adults. Int J Vitam Nutr Res 1999;69:41–4.
134. Gerster H. The role of vitamin C in athletic performance. J Am Coll Nutr 1989;8:636–43 [review].
135. Tiidus PM, Houston ME. Vitamin E status and response to exercise training. Sports Med 1995;20:12–23 [review].
136. Akova B, Surmen-Gur E, Gur H, et al. Exercise-induced oxidative stress and muscle performance in healthy women: role of vitamin E supplementation and endogenous oestradiol. Eur J Appl Physiol 2001;84:141–7.
137. Simon-Schnass I, Pabst H. Influence of vitamin E on physical performance. Int J Vitam Nutr Res 1988;58:49–54.
138. Shepard RJ. Vitamin E and athletic performance. J Sports Med 1983;23:461–70 [review].
139. Dolske MC, Spollen J, McKay S, et al. A preliminary trial of ascorbic acid as supplemental therapy for autism. Prog Neuropsycholpharmacol Biol Psychiatry 1993;17:765–74.
140. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53:352S–5S.
141. Knekt P, Heliovaara M, Rissanen A, et al. Serum antioxidant vitamins and risk of cataract. BMJ 1992;305:1392–4.
142. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between ascorbic acid consumption and levels of total and reduce ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 1991;10:751–9.
143. Reddy VN. Glutathione and its function in the lens—an overview. Exp Eye Res 1990;150:771–8.
144. Packer JE, Slater TF, Wilson RL. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979;278:737–8.
145. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000;118:1556–63.
146. Taylor A. Cataract: relationship between nutrition and oxidation. J Am Coll Nutr 1993;12:138–46 [review].
147. Taylor A, Jacques PF, Nadler D, et al. Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 1991;10:751–9.
148. Jacques PF, Chylack LT Jr. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991;53:352S–5S.
149. Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337–40.
150. Robertson JMD, Donner AP, Trevithick JR. Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci 1989;570:372–82.
151. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Public Health 1994;84:788–92.
152. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol 1999;149:801–9.
153. Chasan-Taber L, Willett WC, Seddon JM, et al. A prospective study of vitamin supplement intake and cataract extraction among U.S. women. Epidemiology 1999;10:679–84.
154. Robertson J McD, Donner AP, Trevithick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr 1991;53:346S–51S.
155. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992;305:335–9.
156. Jacques PF, Taylor A, Hankinson SE, et al. Long-term vitamin C supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr 1997;66:911–6.
157. Holden M, Molloy E. Further experiments on the inactivation of herpes virus by vitamin C (l-ascorbic acid). J Immunol 1937;33:251–7.
158. Terezhalmy GT, Bottomley WK, Pelleu GB. The use of water-soluble bioflavonoid-ascorbic acid complex in the treatment of recurrent herpes labialis. Oral Surg 1978;45:56–62.
159. Johnson K. Antioxidant therapy quickly improves endometriosis pain. Fam Pract News 2004(March 15):75 [News report].
160. Henmi H, Endo T, Kitajima Y, et al. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril 2003;80:459–61.
161. Drake IM, Mapstone NP, Schorah CJ, et al. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication. Gut 1998;42(6):768–71.
162. Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996;38(2):171–6.
163. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, et al. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998;7:449–54.
164. Vaananen MK, Markkanen HA, Tuovinen VJ, et al. Periodontal health related to plasma ascorbic acid. Proc Finn Dent Soc 1993;89:51–9.
165. Aurer-Kozelj J, Kralj-Klobucar N, Buzina R, Bacic M. The effect of ascorbic acid supplementation on periodontal tissue ultrastructure in subjects with progressive periodontitis. Int J Vitam Nutr Res 1982;52:333–41.
166. Woolfe SN, Kenney EB, Hume WR, Carranza FA Jr. Relationship of ascorbic acid levels of blood and gingival tissue with response to periodontal therapy. J Clin Periodontol 1984;11:159–65.
167. Vogel RI, Lamster IB, Wechsler SA, et al. The effects of megadoses of ascorbic acid on PMN chemotaxis and experimental gingivitis. J Periodontol 1986;57:472–9.
168. El-Ashiry GM, Ringsdorf WM, Cheraskin E. Local and systemic influences in periodontal disease. II. Effect of prophylaxis and natural versus synthetic vitamin C upon gingivitis. J Periodontol 1964;35:250–9.
169. Carvel I, Halperin V. Therapeutic effect of water soluble bioflavonoids in gingival inflammatory conditions. Oral Surg Oral Med Oral Pathol 1961;14:847–55.
170. Stein HB, Hasan A, Fox IH. Ascorbic acid-induced uricosuria: a consequence of megavitamin therapy. Ann Intern Med 1976;84:385–8.
171. Huang HY, Appel LJ, Choi MJ, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 2005;52:1843–7.
172. Pike J, Chandra RK. Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vitam Nutr Res 1995;65:117–21.
173. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 1992;340:1124–7.
174. Chavance M, Herbeth B, Lemoine A, et al. Does multivitamin supplementation prevent infections in healthy elderly subjects? A controlled trial. Int J Vitam Nutr Res 1993;63:11–6.
175. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98–107.
176. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr 1998;68:365–71.
177. Gerber WF, Lefkowitz SS, Hung CY. Effect of ascorbic acid, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Pharmacology 1975;13:228.
178. Anderson R. The immunostimulatory, anti-inflammatory an anti-allergic properties of ascorbate. Adv Nutr Res 1984;6:19–45 [review].
179. Banic S. Immunostimulation by vitamin C. Int J Vitam Nutr Res Suppl 1982;23:49–52 [review].
180. Delafuente JC, Prendergast JM, Modigh A. Immunologic modulation by vitamin C in the elderly. Int J Immunopharmacol 1986;8:205–11.
181. Kennes B, Dumont I, Brohee D, et al. Effect of vitamin C supplements on cell-mediated immunity in old people. Gerontology 1983;29:305–10.
182. Murata A. Virucidal activity of vitamin C for prevention and treatment of viral diseases. In Proceedings of the First Intersectional Congress of IAMS, vol 3. Science Council Japan, 1975, 432.
183. Knodell RG, Tate MA, Akl BF, et al. Vitamin C prophylaxis for posttransfusion hepatitis: Lack of effect in a controlled trial. Am J Clin Nutr 1981;34(1):20–3.
184. Hemilä H. Vitamin C and the common cold. Br J Nutr 1992;67:3–16.
185. Hemilä H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int J Sports Med 1996;17:379–83.
186. Penn ND, Purkins L, Kelleher J, et al. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 1991;20:169–74.
187. de la Fuente M, Ferrandez MD, Burgos MS, et al. Immune function in aged women is improved by ingestion of vitamins C and E. Can J Physiol Pharmacol 1998;76:373–80.
188. Renker K, Wegner S. Vitamin C-Prophylaxe in der Volkswertf Stralsund. Deutsche Gesundheitswesen 1954;9:702–6.
189. Klenner FR. The treatment of poliomyelitis and other virus diseases with vitamin C. South Med Surg 1949;111:210–4.
190. Pauling L. Vitamin C, the Common Cold and the Flu. San Francisco: W. H. Freeman & Company, 1976 [review].
191. de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 1997;54:762–5.
192. Scheider WL, Hershey LA, Vena JE, et al. Dietary antioxidants and other dietary factors in the etiology of Parkinson’s disease. Mov Disord 1997;12:190–6.
193. Molina JA, de Bustos F, Jimenez-Jimenez FJ, et al. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson’s disease. J Neural Transm 1997;104:1287–93.
194. Federico A, Battisti C, Formichi P, Dotti MT. Plasma levels of vitamin E in Parkinson’s disease. J Neural Transm Suppl1995;267–70.
195. Morens DM, Grandinetti A, Waslien CI, et al. Case-control study of idiopathic Parkinson’s disease and dietary vitamin E intake. Neurology 1996;46:1270–4.
196. Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson’s disease. Ann Neurol 1992;32:S128–32.
197. Shoulson I. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. Ann Neurol 1998;44:S160–6.
198. Fahn S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson’s disease. Ann Neurol 1992;32:S128–32.
199. Shoulson I. DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism. Ann Neurol 1998;44:S160–6.
200. Vatassery GT, Fahn S, Kuskowski MA. Alpha tocopherol in CSF of subjects taking high-dose vitamin E in the DATATOP study. Parkinson Study Group. Neurology 1998;50:1900–2.
201. Pappert EJ, Tangney CC, Goetz CG, et al. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson’s disease patients: dose-response study and correlations with plasma levels. Neurology 1996;47:1037–42.
202. Dowd PS, Kelleher J, Walker BE, Guillou PJ. Nutrition and cellular immunity in hospital patients. Br J Nutr 1986;55:515–27.
203. Stotts NA, Whitney JD. Nutritional intake and status of clients in the home with open surgical wounds. J Community Health Nurs 1990;7:77–86.
204. Thomas DR. Specific nutritional factors in wound healing. Adv Wound Care 1997;10:40–3 [review].
205. Wendt MD, Soparkar CN, Louie K, et al. Ascorbate stimulates type I and type III collagen in human Tenon’s fibroblasts. J Glaucoma 1997;6:402–7.
206. Vaxman F, Olender S, Lambert A, et al. Effect of pantothenic acid and ascorbic acid supplementation on human skin wound healing process. A double-blind, prospective and randomized trial. Eur Surg Res 1995;27:158–66.
207. Vaxman F, Olender S, Lambert A, et al. Can the wound healing process be improved by vitamin supplementation? Experimental study on humans. Eur Surg Res 1996;28:306–14.
208. Blee TH, Cogbill TH, Lambert PJ. Hemorrhage associated with vitamin C deficiency in surgical patients. Surgery 2002;131:408–12.
209. Casanueva E, Ripoll C, Tolentino M, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr 2005;81:859–63.
210. Sandyk R, Kanofsky JD. Vitamin C in the treatment of schizophrenia. Int J Neurosci 1993;68:67–71.
211. Kanofsky JD, Sandyk R. Antioxidants in the treatment of schizophrenia. Int J Neurosci 1992;62:97–100 [letter].
212. Kanofsky JD, Sandyk R. Antioxidants in the treatment of schizophrenia. Int J Neurosci 1992;62:97–100 [letter].
213. Beauclair L, Vinogradov S, Riney SJ, et al. An adjunctive role for ascorbic acid in the treatment of schizophrenia? J Clin Psychopharmacol 1987;7:282–3 [letter].
214. Pitt B, Pollitt N. Ascorbic acid and chronic schizophrenia. Br J Psychiatry 1971;118:227–8.
215. Grant FW, Cowen MA, Ozerengin MF, Bigelow N. Nutritional requirements in mental illness. I. Ascorbic acid retention in schizophrenia. A reexamination. Biol Psychiatry 1973;5:289–94.
216. Pitt B. Vitamin C and schizophrenia. Lancet 1974;2:1153–4 [letter].
217. Suboticanec K, Folnegovic-Smalc V, Turcin R, et al. Plasma levels and urinary vitamin C excretion in schizophrenic patients. Hum Nutr Clin Nutr 1986;40:421–8.
218. Suboticanec K, Folnegovic-Smalc V, Korbar M, et al. Vitamin C status in chronic schizophrenia. Biol Psychiatry 1990;28:959–66.
219. Houwing R, Overgoor M, Kon M, et al. Pressure-induced skin lesions in pigs: reperfusion injury and the effects of vitamin E. J Wound Care 2000; 9:36–40.
220. Lucero MJ, Vigo J, Rabasco AM, et al. Protection by alpha-tocopherol against skin necrosis induced by doxorubicin hydrochloride. Pharmazie 1993;48:772–5.
221. Shukla A, Rasik AM, Patnaik GK. Depletion of reduced glutathione, ascorbic acid, vitamin E, and antioxidant defence enzymes in a healing cutaneous wound. Free Radic Res 1997;26:93–101.
222. Ramasastry, SS, Angel MF, Narayanan K, et al. Biochemical evidence of lipoperoxidation in venous stasis ulcer: Beneficial role of vitamin E as antioxidant. Ann NY Acad Sci 1989; 506–8.
223. Hajarizadeh H, Lebredo L, Barrie R, Woltering EA. Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig. Ann Surg Oncol 1994;1:411–4.
224. Goode HF, Burns E, Walker BE. Vitamin C depletion and pressure sores in elderly patients with femoral neck fracture. BMJ 1992;305:935–7.
225. Afifi AM, Ellis L, Huntsman RG, Said MI. High dose ascorbic acid in the management of thalassaemia leg ulcers—a pilot study. Br J Dermatol 1975;92:339–41.
226. Taylor TV, Rimmer S, Day B, et al. Ascorbic acid supplementation in the treatment of pressure cores. Lancet 1974;ii:544–6.
227. ter Riet G, Kessels AG, Knipschild PG. Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers. J Clin Epidemiol 1995;48:1453–60.
228. Kanter M. Free radicals, exercise and antioxidant supplementation. Proc Nutr Soc 1998;57:9–13 [review].
229. Jakeman P, Maxwell S. Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise. Eur J Appl Physiol 1993;67:426–30.
230. Kaminski M, Boal R. An effect of ascorbic acid on delayed-onset muscle soreness. Pain 1992;50:317–21.
231. McBride JM, Kraemer WJ, Triplett-McBride T, et al. Effect of resistance exercise on free radical production. Med Sci Sports Exerc 1998;30:67–72.
232. Rokitzki L, Logemann E, Huber G, et al. alpha-Tocopherol supplementation in racing cyclists during extreme endurance training. Int J Sport Nutr 1994;4:253–64.
233. Meydani M, Evans WJ, Handelman, et al. Protective effect of vitamin E on exercise-induced oxidative damage in young and older adults. Am J Physiol 1993;264(5 pt 2):R992–8.
234. Tiidus PM, Houston ME. Vitamin E status and response to exercise training. Sports Med 1995;20:12–23 [review].
235. Kaikkonen J, Kosonen L, Nyyssonen K, et al. Effect of combined coenzyme Q10 and d-alpha-tocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners. Free Radic Res 1998;29:85–92.
236. Levine M. New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 1986;314:892–902 [review].
237. Mazzotta MY. Nutrition and wound healing. J Am Podiatr Med Assoc 1994;84:456–62 [review].
238. Mazzotta MY. Nutrition and wound healing. J Am Podiatr Med Assoc 1994;84:456–62 [review].
239. Ringsdorf WM Jr, Cheraskin E. Vitamin C and human wound healing. Oral Surg Oral Med Oral Pathol 1982;53:231–6 [review].
240. Gey GO, Cooper KH, Bottenberg RA. Effect of ascorbic acid on endurance performance and athletic injury. JAMA 1970;211:105.
241. Lin JY, Selim MA, Shea CR, et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol 2003;48:866–74.
242. Burke KE, Burford RG, Combs GF Jr, et al. The effect of topical L-selenomethionine on minimal erythema dose of ultraviolet irradiation in humans. Photodermatol Photoimmunol Photomed 1992;9:52–7.
243. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology 1997;195:248–52.
244. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 1996;288:522–6.
245. Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol 1998;139:332–9.
246. Dreher F, Denig N, Gabard B, et al. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology 1999;198:52–5.
247. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic Biol Med 1998;25:848–73 [review].
248. Lin JY, Selim MA, Shea CR, et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol 2003;48:866–74.
249. Burke KE, Burford RG, Combs GF Jr, et al. The effect of topical L-selenomethionine on minimal erythema dose of ultraviolet irradiation in humans. Photodermatol Photoimmunol Photomed 1992;9:52–7.
250. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Influence of the application time point. Dermatology 1997;195:248–52.
251. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study. Arch Dermatol Res 1996;288:522–6.
252. Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol 1998;139:332–9.
253. Dreher F, Denig N, Gabard B, et al. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatology 1999;198:52–5.
254. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic Biol Med 1998;25:848–73 [review].
255. Cunningham JJ, Ellis SL, McVeigh KL, et al. Reduced mononuclear leukocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C. Metabolism1991;40:146–9.
256. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes1992;41:167–73.
257. Will JC, Tyers T. Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev1996;54:193–202 [review].
258. McAuliffe AV, Brooks BA, Fisher EJ, et al. Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron1998;80:277–84.
259. Branch DR. High-dose vitamin C supplementation increases plasma glucose. Diabetes Care 1999;22:1218 [letter].
260. Mayer-Davis E, Bell RA, Reboussin BA, et al. Antioxidant nutrient intake and diabetic retinopathy. The San Luis Valley Diabetes Study. Ophthalmology1998;105:2264–70.
261. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes 1992;41:167–73.
262. Will JC, Tyers T. Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 1996;54:193–202 [review].
263. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 1995;39:217–23.
264. Paolisso G, Balbi V, Volpe C, et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 1995;14:387–92.
265. Will JC, Tyers T. Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 1996;54:193–202 [review].
266. McAuliffe AV, Brooks BA, Fisher EJ, et al. Administration of ascorbic acid and an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion. Nephron 1998;80:277–84.
267. Branch DR. High-dose vitamin C supplementation increases plasma glucose. Diabetes Care 1999;22:1218 [letter].
268. Mayer-Davis E, Bell RA, Reboussin BA, et al. Antioxidant nutrient intake and diabetic retinopathy. The San Luis Valley Diabetes Study. Ophthalmology 1998;105:2264–70.
269. Sirsi M. Antimicrobial action of vitamin C on M. tuberculosis and some other pathogenic organisms. Indian J Med Sci 1952;6:252–5.
270. Axelrod DR. Ascorbic acid and urinary pH. JAMA 1985;254:1310–1.
271. Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, et al. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand 2007;86:783–7.
272. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000;54:1265–72.
273. Replogle WH, Eicke FJ. Megavitamin therapy in the reduction of anxiety and depression among alcoholics. J Orthomolec Med 1988;4:221–4.
274. Morgan MY, Levine JA. Alcohol and nutrition. Proc Natl Acad Sci 1988;47:85–98.
275. Chapman K, Prabhudesai M, Erdman JW. Vitamin A status of alcoholics upon admission and after two weeks of hospitalization. J Am Coll Nutr 1993;12:77–83.
276. Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 1999;69:1071–85 [review].
277. Chen M, Boyce W, Hsu JM. Effect of ascorbic acid on plasma alcohol clearance. J Am Coll Nutr 1990;9:185–9.
278. Igarashi M. Augmentative effect of ascorbic acid upon induction of human ovulation in clomiphene-ineffective anovulatory women. Int J Fertil 1977;22:168–73.
279. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci 1993;90:7915-22.
280. Grievink L, Zijlstra AG, Ke X, Brunekreef B. Double-blind intervention trial on modulation of ozone effects on pulmonary function by antioxidant supplements. Am J Epidemiol 1999;149:306-14.
281. Trenga CA, Koenig JQ, Williams PV. Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma. Arch Environ Health 2001;56:242-9.
282. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Tellez-Rojo MM, Moreno-Macias H, Reyes-Ruiz NI, et al. Antioxidant supplementation and lung functions among children with asthma exposed to high levels of air pollutants. Am J Respir Crit Care Med 2002;166:703-9.
283. Naylor GJ. Vanadium and manic depressive psychosis. Nutr Health 1984;3:79–85 [review].
284. Naylor GJ, Smith AH. Vanadium: a possible aetiological factor in manic depressive illness. Psychol Med 1981;11:249–56.
285. Kay DS, Naylor GJ, Smith AH, Greenwood C. The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments. Psychol Med 1984;14:533–9.
286. Jariwalla RJ, Harakeh S. Antiviral and immunomodulatory activities of ascorbic acid. Subcell Biochem 1996;25:213–31 [review].
287. Stone I. The Healing Factor: Vitamin C Against Disease. New York: Perigee Books, 1972, 75.
288. Tanzer F, Ozalp I. Leucocyte ascorbic acid concentration and plasma ascorbic acid levels in children with various infections. Mater Med Pol 1993;25:5–8.
289. Joffe MI, Sukha NR, Rabson AR. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid. J Clin Invest 1983;72:971–80.
290. Sridhar MK. Nutrition and lung health. BMJ 1995;310:75–6.
291. Shibata A, Paganini-Hill A, Ross RK, Henderson BE. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992;66:673–9.
292. Bussey HJR, DeCosse JJ, Deschner EE, et al. A randomized trial of ascorbic acid in polyposis coli. Cancer 1982;50:1434–9.
293. Ponz de Leon M, Roncucci L. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scand J Gastroenterol Suppl 1997;222:72–5.
294. Greenburg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141–7.
295. McKeown-Eyssen G, Holloway C, Jazmaji V, et al. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 1988;48:4701–5.
296. DeCosse JJ, Miller HH, Lesser ML. Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 1989;81:1290–7.
297. Hanck A. Vitamin C and cancer. Int J Vit Nutr Res 1983;(Suppl #24):87–104 [review].
298. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1976;73:3685–9.
299. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci USA 1978;75:4538–42.
300. Creagan ET, Moertel CG, O’Fallon JR, et al. Failure of high dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979;301:687–90.
301. Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. New Engl J Med 1985;312(3):137–41.
302. Murata A, Morishige F, Yamaguchi H. Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int J Vit Nutr Res 1982;(Suppl #23):103–14.
303. Leibovitz B, Siegel BV. Ascorbic acid, neutrophil function, and the immune response. Int J Vitam Nutr Res 1978;48:159–64.
304. Vojdani A, Ghoneum M. In vivo effect of ascorbic acid on enhancement of human natural killer cell activity. Nutr Res 1993;13:753–64.
305. Anonymous. Severe atopic dermatitis responds to ascorbic acid. Med World News 1989;April 24:41.
306. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults. Arch Intern Med 2000;160:931–6.
307. Simon JA. Ascorbic acid and cholesterol gallstones. Med Hypotheses 1993;40:81–4.
308. Simon JA, Grady D, Snabes MC, et al. Ascorbic acid supplement use and the prevalence of gallbladder disease. J Clin Epidemiol 1998;51:257–65.
309. Gustafsson U, Wang F-H, Axelson M, et al. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest 1997;27:387–91.
310. Vaananen MK, Markkanen HA, Tuovinen VJ, et al. Periodontal health related to plasma ascorbic acid. Proc Finn Dent Soc 1993;89:51–9.
311. Murray M, Pizzorno J. Encyclopedia of Natural Medicine, rev2d ed. Rocklin, CA: Prima Publishing, 1998, 722–9.
312. Pack AR. Folate mouthwash: effects on established gingivitis in periodontal patients. J Clin Periodontol 1984;11:619–28.
313. Holmes HM, Alexander W. Hay fever and vitamin C. Science 1942;96:497.
314. Ruskin SL. High dose vitamin C in allergy. Am J Dig Dis 1945;12:281.
315. Fortner BR Jr, Danziger RE, Rabinowitz PS, Nelson HS. The effect of ascorbic acid on cutaneous and nasal response to histamine and allergen. J Allergy Clin Immunol 1982;69:484–8.
316. Chambers JC, McGergor A, Jean-Marie J, et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia. An effect reversible with vitamin C therapy. Circulation 1999;99:1156–60.
317. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996;119:139–50.
318. Rath M, Pauling L. Solution to the puzzle of human cardiovascular disease: Its primary cause is ascorbate deficiency leading to the deposition of lipoprotein (a) and fibrinogen/fibrin in the vascular wall. J Orthomol Med 1992;6:125–34.
319. Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of vitamin C and incidence of coronary heart disease in women. Circulation 1992;85:865 [abstract].
320. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69:261–6.
321. Nyyssönen K, Parvianinen MT, Salonen R, et al. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997;314:634–8.
322. Simon JA, Hudes ES, Browner WS. Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiology 1998;9:316–21.
323. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450–6.
324. Morishige F, Murata A. Vitamin C for prophylaxis of viral hepatitis B in transfused patients. J Int Acad Prev Med 1978;5(1):54–8.
325. Knodell RG, Tate MA, Akl BF, Wilson JW. Vitamin C prophylaxis for post transfusion hepatitis: lack of effect in a controlled trial. Am J Clin Nutr 1981;34:20–3.
326. Baur H, Staub H. Treatment of hepatitis with infusions of ascorbic acid: comparison with other therapies. JAMA 1954;156:565 [abstract].
327. Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci 1990;87:7245–9.
328. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency type 1 infection. Am J Epidemiol 1996;143:1244–56.
329. Cathcart RF III. Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS). Med Hypotheses 1984;14:423–33.
330. Johnston S, Martin LJ, Cai X. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis. J Am Coll Nutr 1992;11:172–6.
331. Johnston S, Martin LJ, Cai X. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis. J Am Coll Nutr 1992;11:172–6.
332. Ness AR, Chee D, Elliott P. Vitamin C and blood pressure—an overview. J Human Hypertens 1997;11:343–50.
333. Fotherby MD, Williams JC, Forster LA, et al. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 2000;18:411–5.
334. Anderson RA et al. Chromium supplementation of humans with hypoglycemia. Fed Proc 1984;43:471.
335. Stebbing JB et al. Reactive hypoglycemia and magnesium. Magnesium Bull 1982;2:131–4.
336. Shansky A. Vitamin B3 in the alleviation of hypoglycemia. Drug Cosm Ind 1981;129(4):68–69,104–5.
337. Gaby AR, Wright JV. Nutritional regulation of blood glucose. J Advancement Med 1991;4:57–71.
338. Garewal H. Antioxidants in oral cancer prevention. Am J Clin Nutr 1995;62(suppl):1410S–6S [review].
339. Kaugars GE, Silverman S Jr, Lovas JG, et al. A clinical trial of antioxidant supplements in the treatment of oral leukoplakia. Oral Surg Oral Med Oral Pathol 1994 Oct;78:462–8.
340. Zaridze D, Evstifeeva T, Boyle P. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer. Ann Epidemiol 1993;3:225–34.
341. Greenwood J. Optimum vitamin C intake as a factor in the preservation of disc integrity. Med Ann District of Columbia 1964;33:274–6.
342. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988:32:252–69.
343. Katz ML, Parker KR, Handelman GJ, et al. Effects of antioxidant nutrient deficiency on the retina and retinal pigment epithelium of albino rats: a light and electron microscopic study. Exp Eye Res 1982;34:339–69.
344. West S, Vitale S, Hallfrisch J, et al. Are anti-oxidants or supplements protective of age-related macular degeneration? Arch Ophthalmol 1994:112:222–7.
345. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993:111:104–9.
346. Goldberg J, Flowerdew G, Smith E, et al. Factors associated with age-related macular degeneration. Am J Epidemiol 1988:128:700–10.
347. Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 1999;106:761–7.
348. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998;76:224–9.
349. CJ Smith. Non-hormonal control of vaso-motor flushing in menopausal patients. Chicago Med 1964;67:193–5.
350. Cohen JD, Rubin HW. Functional menorrhagia: treatment with bioflavonoids and vitamin C. Curr Ther Res Clin Exp 1960;2:539–42.
351. Mukherjee GG, Gajaraj AJ, Mathias J, Marya D. Treatment of abnormal uterine bleeding with micronized flavonoids. Int J Gynaecol Obstet2005;89:156–7.
352. Merkel RL. The use of menadione bisulfite and ascorbic acid in the treatment of nausea and vomiting of pregnancy. Am J Obstet Gynecol 1952;64:416–8.
353. Sirsi M. Antimicrobial action of vitamin C on M.tuberculosis and some other pathogenic organisms. Indian J Med Sci 1952;6:252–5.
354. Axelrod DR. Ascorbic acid and urinary pH. JAMA 1985;254:1310–1 [letter].
355. Lundberg JO, Carlsson S, Engstrand L, et al. Urinary nitrite: more than a marker of infection. Urology 1997;50:189–91.
356. Tangney CC, Phillips G, Bell RA, et al. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol 1989;32:161–6.
357. Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients with sickle cell anemia. Am J Pediatr Hematol Oncol 1990;12:262–7.
358. Jain SK, Ross JD, Duett J, Herbst JJ. Low plasma prealbumin and carotenoid levels in sickle cell disease patients. Am J Med Sci 1990;229:13–5.
359. Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vitro. Clin Chim Acta 1985;149:257–61.
360. Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, Bowen P. Low serum levels of carotenoids in sickle cell anemia. Eur J Haematol 1988;41:131–5.
361. Essein, EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia. Centr Afr J Med 1995;41:48–50.
362. Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in children with sickle cell anemia. East Afr Med J 1990;67:720–5.
363. Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia. Am J Hematol 1992;41:227–31.
364. Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr 1980;33:968–71.
365. Muskiet FA, Muskiet FD, Meiborg G, Schermer JG. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr 1991;54:736–44.
366. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 2001;85:966–74.
367. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 2001;85:966–74.
368. Clemetson, CA. Histamine and ascorbic acid in human blood. J Nutr 1980;110:662–8.
369. Bucca C, Rolla G, Oliva A, Farina JC. Effect of vitamin C on histamine bronchial responsiveness of patients with allergic rhinitis. Ann Allergy 1990;65:311–4.
370. Bellioni P, Artuso A, Di Luzio Paparatti U, Salvinelli F. Histaminic provocation in allergy. The role of ascorbic acid. Riv Eur Sci Med Farmacol 1987;9:419–22 [in Italian].
371. Nikolaev MP, Longunov AI, Tsyrulnikova LG, Dzhalilov DS. Clinical and biochemical aspects in the treatment of acute maxillary sinusitis with antioxidants. Vestn Otorinolaringol 1994;Jan/Feb:22–6.
372. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5–8.
373. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.
374. Crary EJ, McCarty MF. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses 1984;13:77–98.
375. Crary EJ, McCarty MF. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses 1984;13:77–98.
376. Crary EJ, McCarty MF. Potential clinical applications for high-dose nutritional antioxidants. Med Hypotheses 1984;13:77–98.
377. Montes LF, Diaz ML, Lajous J, Garcia NJ. Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis 1992;50:39–42.
378. Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 1997;77:460–2.
379. Balz F. Antioxidant Vitamins and Heart Disease. Presented at the 60th Annual Biology Colloquium, Oregon State University, February 25, 1999.
380. Levine M, Rumsey SC, Daruwala R, et al. Criteria and recommendations for vitamin C intake. JAMA 1999;281:1415–23.
381. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 1996;93:3704–9.
382. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999;69:1086–107.
383. Hemilä H. Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit. Med Hypotheses 1999;52:171–8 [review].
384. Kharb S. Total free radical trapping antioxidant potential in pre-eclampsia. Int J Gynaecol Obstet 2000;69:23–6.
385. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults. Arch Intern Med 2000;160:931–6.
386. Makoff R. Vitamin replacement therapy in renal failure patients. Miner Electrolyte Metab 1999;25:349–51 [review].
387. Sandstead HH. Copper bioavailability and requirements. Am J Clin Nutr 1982;35:809–14 [review].
388. Finley EB, Cerklewski FL. Influence of ascorbic acid supplementation on copper status in young adult men. Am J Clin Nutr 1983;37:553–6.
389. Johnston CS. Biomarkers for establishing a tolerable upper intake level for vitamin C. Nutr Rev 1999;57:71–7.
390. Wilson JD. Vitamin deficiency and excess. In Fauci AS, Braunwald E, Isselbacher KJ, et al. (eds). Harrison’s Principles of Internal Medicine, 14th ed. New York, McGraw Hill, 1998, 487.
391. Cochrane WA. Overnutrition in prenatal and neonatal life: a problem? Can Med Assoc J 1965;93:893–9.
392. Gaby AR. The myth of rebound scurvy. Townsend Letter for Doctors 2000;June:122.
393. Dwyer J, Nicholson LM, Shircore A, et al. Vitamin C intake and progression of carotid atherosclerosis. The Los Angeles Atherosclerosis Study. American Heart Association Annual Meeting. March 2, 2000 [abstract].
394. Piesse JW. Nutritional factors in calcium containing kidney stones with particular emphasis on vitamin C. Int Clin Nutr Rev 1985;5:110–29 [review].
395. Ringsdorf WM, Cheraskin WM. Medical complications from ascorbic acid: a review and interpretation (part one). J Holistic Med 1984;6:49–63.
396. Hoffer A. Ascorbic acid and kidney stones. Can Med Assoc J 1985;32:320 [letter].
397. Wandzilak TR, D’Andre SD, Davis PA, Williams HE. Effect of high dose vitamin C on urinary oxalate levels. J Urol 1994;151:834–7.
398. Levine M. Vitamin C and optimal health. Presented at the February 25, 1999 60th Annual Biology Colloquium, Oregon State University, Corvallis, Oregon.
399. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 1996;93:3704–9.
400. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695–700.
401. Branch DR. High-dose vitamin C supplementation increases plasma glucose. Diabetes Care1999;22:1218 [letter].
Last Review: 05-11-2011
Copyright © 2011 Aisle7. All rights reserved. www.Aisle7.net
Learn more about Aisle7, the company.
The information presented in Aisle7 is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires June 2011.
© 1995-2011 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Welcome to Care Circle, an exclusive tool to help you take care of yourself and your loved ones. Here's how it works:
The information you input is strictly private; you choose who has access to your Care Circle.
How do I add myself or someone else to my care circle?
Click on "Add someone." Fill out the short profile. Choose an avatar. Select the topics and conditions that interest this person from the pulldown menu. You can select as many as you want, but you must choose at least one. Click on "Add Someone" again. You should start getting updates immediately.
How do I save content to my Care Circle?
Click on "Manage My Care Circle." Select the tab of the person for whom you're saving content. Put your cursor over the piece of content that you want to save; a disk icon will appear in the righthand corner. Click on the disk and the piece of content will be moved to a save folder.
How do I add additional topics and conditions for someone in my Care Circle?
Click on "Manage My Care Circle." Select the tab for the person whose preferences you'd like to update. Under "Add More to Follow," select additional topics and conditions.
How do I delete topics and conditions for someone in my Care Circle?
Click on "Manage My Care Circle." Select the tab for the person whose preferences you'd like to update. Under "Follows," scroll over the topic or condition you want to delete. An "X" should appear on the righthand side. Click on the "X" and the topic or condition will be deleted from the list.